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Abstract
Background: Efficacy of self-help internet-based cognitive behavior therapy (ICBT) for anxiety disorders has been
confirmed in several randomized controlled trials. However, the amount and type of therapist guidance needed in
ICBT are still under debate. Previous studies have shown divergent results regarding the role of therapist guidance
and its impact on treatment outcome. This issue is central to the development of ICBT programs and needs to be
addressed directly. The present study aims to compare the benefits of regular therapist guidance via online real-
time audio-video communication (i.e. Skype) to no therapist guidance during a 12-week Romanian self-help ICBT
program for Panic Disorder. Both treatments are compared to a waiting-list control group.
Methods/Design: A parallel group randomized controlled trial is proposed. The participants, 192 Romanian adults
fulfilling diagnostic criteria for panic disorder according to a diagnostic interview, conducted via secured Skype or
telephone, are randomly assigned to one of the three conditions: independent use of the internet-based self-help
program PAXonline, the same self-help treatment with regular therapist support via secured Skype, and waiting-list
control group. The primary outcomes are severity of self-report panic symptoms (PDSS-SR) and diagnostic status
(assessors are blind to group assignment), at the end of the intervention (12 weeks) and at follow-up (months 3
and 6). The secondary measures address symptoms of comorbid anxiety disorders, depression, quality of life,
adherence and satisfaction with ICBT. Additional measures of socio-demographic characteristics, personality traits,
treatment expectancies, catastrophic cognitions, body vigilance and working alliance are considered as potential
moderators and/ or mediators of treatment outcome.
Discussion: To the best of our knowledge, the present study is the first effort to investigate the efficacy of a self-
help internet-based intervention with therapist guidance via real-time video communication. A direct comparison
between therapist guided versus unguided self-directed intervention for panic disorder will also be addressed for
the first time. Findings from this study will inform researchers and practitioners about the added value of online
video-therapy guidance sessions and the type of patients who may benefit the most from guided and unguided
ICBT for Panic disorder.
Trial registration: ACTRN12614000547640 (Australian New Zealand Clinical Trials Registry). Registered 22/05/2014.
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Background
Hundreds of millions of people are affected by mental
health disorders worldwide and failing to adequately
address this issue brings significant suffering, disability
and economic loss. The lifetime prevalence for mental
health disorders in general is above 46 %, with the high-
est prevalence recorded for anxiety disorders, given that
almost 1 out of 3 people (28.8 %) suffer from an anxiety
disorder during their lifetime [1]. Every year over 38.2 %
(164.7 million people) of the total EU population suffer
from at least one mental disorder and the resulting eco-
nomic costs rise at 3–4 % of EU Gross Domestic Prod-
uct (GDP) [2].
One third of medical consultations made by general
practitioners are in fact provided for mental health prob-
lems [3–5]. A report released by WHO (World Health
Organization) and WONCA (World Organization of
Family Doctors) in 2008 stated that “up to 60 % of people
attending primary care clinics have a diagnosable mental
disorder” (page VII) [6]. There is an alarming underdetec-
tion of mental health problems – for example, detection
rates of anxiety and mood disorders in general practice
reach only 15 and 36 %, respectively [7, 8]. Moreover,
collaboration between GPs and mental health services is
either poor or non-existent.
Despite the potential to successfully treat mental disor-
ders, only a small minority receive even the most basic
treatment. Studies have shown that 60 % of those in need
receive no treatment at all, and only 32.7 % of those who
receive treatment get it at minimal quality standards [9].
Furthermore, there are numerous individual and systemic
barriers to accessing mental health services [10], thus the
treatment is provided only with a significant delay from
the onset of the disorder (after 9–23 years for anxiety dis-
orders and 6–8 years for mood disorders) [11]. In some
countries, the situation is even worse. In Romania, where
the current study is conducted, 76.4 % of the individuals
with mental health disorders do not have access to any
form of treatment; only about 11.5 % receive psychological
or psychiatric help [12].
Computer and Internet-based cognitive behavioral
treatments (ICBT) represent recent attempts to innovate
the psychotherapeutic process, matching both the exist-
ent demands of the market, and the new attitudes of
those who seek help in the digital era. Research on
internet-based treatments has grown rapidly in the past
decade, gathering more than 100 controlled studies that
tested various intervention programs for anxiety disor-
ders, mood disorders, or other psychiatric conditions
[13–15]. Overall, the outcomes of these studies have
been positive and very convincing. Several studies re-
ported no significant differences in treatment outcomes
when comparing internet-based interventions to trad-
itional face-to-face therapy [16–21]. For a review see
Andersson et al. [22]. Because half of all lifetime cases of
mental disorders start by age 14 years and the median
age of onset for anxiety is 11 years [1], it should be men-
tioned that ICBT shows promising results not just for
adults, but also for treating anxiety and depression in
youth [23, 24]. Anxiety disorders seem to be one of the
most approachable and treatable types of mental dis-
order through online therapy [25–31]. Panic disorder
(PD) with or without agoraphobia is one of the condi-
tions for which ICBT programs have been developed
since the late 1990s and there are several empirical stud-
ies supporting their efficacy and effectiveness [13, 17, 19,
32–42]. In Romania, only one internet-based treatment
has been tested so far, the Swedish program Sofie [43].
The study yielded positive outcomes for the treatment of
social anxiety disorder, but the program is currently not
in use.
The most promising interventions designed and tested
so far are guided self-help interventions. A guided ICBT
intervention is a web-based self-help program combined
with minimal, but regular therapist support. In guided
programs, asynchronous communication (emails or text
messages) is most commonly used and, on average,
patient guidance does not take more than 10 min per
week [44]. So far, research is very limited regarding web-
based treatment programs that provide guidance
through synchronous (real time) audio-video communi-
cation (e.g. video chat programs such as Skype). On the
other hand, there is growing evidence that the efficacy of
CBT delivered via videoconference is equivalent to face-
to-face treatment for mood and anxiety disorders [45–
50]. This type of communication closely matches face-
to-face therapy and enables access to important face-to-
face cues such as verbal tone, facial expressions, and
body language. Through synchronous guidance, the
therapists may be able to offer more individually tailored
feedback and support according to each patient’s per-
sonal needs. Furthermore, this type of contact may facili-
tate higher engagement, feelings of accountability and
social support, and reduce the risk of misunderstand-
ings, compared to emails and instant messaging [51]. All
of the above could also facilitate the development of a
better therapeutic alliance [52], a factor that has consist-
ently proven to be a key predictor for therapeutic change
in face-to-face therapy [53, 54]. So far, there is mixed
evidence regarding the importance of the therapeutic al-
liance in guided ICBT [44]. Even if contact with the
therapist is only minimal, patients seem to develop a
strong alliance, but this makes no difference for the out-
come, at least for self-help interventions with rather
low-intensity guidance [44]. However, the therapeutic al-
liance in internet-based treatments that include video
conferencing is yet to be investigated [55]. Of course,
there are also disadvantages for using real-time audio-
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video communication. For instance, compared to asyn-
chronous written exchanges, patients do not have the
opportunity to revisit and reread the dialogues with their
therapists [51]. The patients are still able to revisit and
reflect upon the information enclosed in the treatment
modules, but they cannot review their guidance sessions.
It is still not clear enough whether guided online treat-
ments work better than unguided treatments [18, 31,
56–59], however there is a strong tendency for the su-
periority of guided treatment, especially for depression
[14, 60]. So far, the literature suggests a superiority of
guided versus unguided self-help treatments in terms
of efficacy, adherence to treatment and drop-out rates
[14, 61–63], but the conclusions are based on few
studies and mainly limited to depression and social
anxiety disorder, thus restricting the generalizability of
the findings [64].
There is good quality evidence that ICBT treatments,
especially guided interventions, are both efficacious and
effective, either compared with waiting-list or with face
to face interventions, but there is no intervention that is
suitable for everyone [44]. In order to be able to make
recommendations for a certain person, with certain
characteristics, we need to know which variables can
predict or mediate/ moderate the outcomes. Unfortu-
nately, the studies conducted so far showed that there
are few stable predictors across studies and diagnoses
[65]. For example, treatment adherence was considered
as a potential predictor variable, but there are inconsist-
encies, with some studies finding an association between
adherence and clinical outcomes [66–68] and others not
[65, 69, 70]. Another example is the severity of the dis-
order at baseline. In one study, a high baseline severity
predicted better outcomes [71], while another study
showed the contrary, low levels of panic symptom sever-
ity predicting better outcomes [65]. Another inter-
esting result concerns the role of comorbidity. A recent
study showed that having a comorbid anxiety disorder
was associated with a better treatment outcome among
patients with panic disorder but not patients with social
anxiety disorder [72], while others found no significant
association [65, 73]. Considering these mixed results, we
agree with Andersson who concluded “We do not know
much about predictors of treatment outcome and the
mechanisms involved in generating good outcome. Thus,
more studies on moderators and mediators are needed”
([44], p.106).
Objectives and research questions
The aim of the present trial is to investigate the clinical
efficacy of an internet-based self-help treatment program
for panic disorder with therapist guidance via secured
Skype in Romanian adults. The program (PAXonline for
panic disorder) has been developed de novo by the
authors, based on empirically validated cognitive-behavioral
models of anxiety disorders [74–76], and it is currently the
only available psychological treatment of this kind in
Romania. A secondary objective is to compare the guided
self-help intervention to a similar but unguided interven-
tion program, considering clinical outcomes, adherence to
treatment and drop-out. Additional exploratory research
will be conducted to identify potential predictors, modera-
tors and mediators of treatment outcome, such as patients’
expectations, patient-therapist working alliance, panic
disorders severity and comorbidity status, and other rele-
vant factors that were chosen based on previous research
findings.
Methods/ Design
The study design is reported in line with the CONSORT
2010 statement (Consolidated Standards of Reporting
Trials) [77] and the SPIRIT 2013 Statement (Standard
Protocol Items: Recommendations for Interventional
Trials) [78].
Study design
This study is a randomized controlled trial with two ac-
tive treatment conditions and a waiting list control
group. A one-factor experimental design (parallel-group,
superiority trial) will be used. The three conditions are:
1. Web-based self-help program for panic disorder with
intensive guidance (PAX-guided): participants in this
group will complete the PAXonline panic disorder
treatment program with support from a therapist,
which include weekly emails and regular 15-30 min
Skype sessions. In total, there will be 10 Skype
sessions available.
2. Web-based self-help program (PAX-unguided):
participants in this group will complete the
PAXonline panic disorder program in a self-guided
format, i.e. without any support from a therapist.
3. Waiting list control group. This group will not
receive any treatment for 12 weeks. At the end of
the waiting period, the participants receive any of
the two treatment programs, depending on their
choice.
Ethical approval
The study has been approved by the Ethical Review Board
of The Center for the Management of Scientific Research
Babes-Bolyai University (No. 31697/ 12.05.2014), and has
been prospectively registered in Australian New Zealand
Clinical Trials Registry (ACTRN12614000547640, 22/05/
2014). See Table 1 for the WHO Trial Registration Data
Set.
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Table 1 Trial registration data set as recommend by World Health Organization (WHO)
Data category Information
Primary registry and trial
identifying number
Australian New Zealand Clinical Trial Registry (ANZCTR), ACTRN12614000547640
Date of registration in primary
registry
22.05.2014
Secondary identifying numbers Nil, U1111-1156-7294, 366360, 31697
Source(s) of monetary or material
support
Babes-Bolyai University, Faculty of Psychology; Sciex - Scientific Exchange Programme NMS.CH; The Romanian
Association for Online Counselling and Psychotherapy (ACPOR)
Primary sponsor Babes-Bolyai University, Faculty of Psychology; 37, Republicii Street, Cluj-Napoca, 400015, Cluj
Secondary sponsor(s) Sciex - Scientific Exchange Programme NMS.CH; CRUS Sciex-MPC, P.O. Box 607, CH-3000 Berne 9
ACPOR- Cluj-Napoca, Romania
Contact for public queries Babes-Bolyai University, School of Psychology and Educational Sciences, Department of Psychology
Mr Mircea Miclea, Mr Liviu G. Crisan (mirceamiclea@gmail.com; liviugcrisan.neuro@gmail.com)
Contact for scientific queries Ms Amalia Ciuca (amalia.ciuca@psy.unibe.ch; amaliaciuca@psychology.ro) Babes-Bolyai University, School of
Psychology and Educational Sciences;
Public title PAXonline: A Randomized Controlled Trial Assessing the Efficacy of an Internet-Based Cognitive Behavior
Intervention for Panic Disorder
Scientific title PAXonline: A Randomized Controlled Trial Comparing the Efficacy of an Internet-Based Cognitive Behavior
Intervention, delivered with or without assistance from a therapist, to waiting-list in Romanian adults with
Panic Disorder
Countries of recruitment Romania, Spain, Italy
Health condition(s) or problem(s)
studied
Mental health, anxiety disorders
Intervention(s) Active comparators: Internet cognitive-behavioral treatment for panic disorder offered with or without assistance
from a psychotherapist
Placebo comparator: waiting list group.
Key inclusion and exclusion
criteria
Inclusion criteria: diagnostic of Panic Disorder (confirmed by an experienced clinician through semi-structured
clinical interview); age within the range of 18–65 years; access to a computer with internet connection; written
informed consent provided; no participation in psychological treatment for panic disorder in the last 3 months.
Exclusion criteria: severe comorbidities (e.g. bipolar disorders, psychotic disorders, substance abuse); mental
retardation; suicidal ideation or behaviors; benzodiazepines treatment
Study type Interventional
Allocation: randomized; Intervention model: parallel assignment Masking: blind outcomes assessment
Primary purpose: treatment
Date of first enrolment 28 May 2014
Target sample size 120 (the target sample size was changed to 192, but an official change was not made in the registry)
Recruitment status Recruiting
Primary outcome(s) Symptoms and severity of panic disorder (PDSS-SR); The Agoraphobic Cognitions Questionnaire; The Body
Sensations Questionnaire
Key secondary outcomes Symptoms and severity of depression - Patient Health Questionnaire-9 (PHQ-9); The Work and Social Adjustment
Scale; the Working Alliance Inventory Short Revised (WAI-SR); Psychiatric Diagnostic and Screening Questionnaire
(PDSQ); Panic Attack Cognition Questionnaire (PACQ); SS-5 - a 5-item shortened version of the Medical Outcomes
Study Social Support Scale (MOS-SSS); Credibility/ Expectancy Questionnaire (CEQ); Body vigilance scale (BVS);
Dependent personality disorder traits (Scale from OMNI-IV - Personality Disorder Inventory); System Usability Scale
(SUS).
Issue date: 17.11.2015
Protocol amendment number: 02
Revision chronology
UM 00, 22.05.2014 Original
UM 01, 17.07.2015 Amendment 01: Changes were registered in Section 4 regarding secondary outcomes (OMNI-IV Dependent Personality Subscale was added)
and in Section 8 regarding funding and sponsors (Sciex - Scientific Exchange Programme NMS.CH was added)
UM 02, 17.11.2015 Amendment 02: The time period for recruiting was extended
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Participants
Native Romanian speakers with Panic Disorder (n = 192)
will be recruited via media (TV news, internet advertise-
ments, and social media), promotional advertising displayed
in emergency rooms, and direct recommendations made by
a network of general practitioners and psychotherapists.
Inclusion and exclusion criteria
Participants are included in the study if the following
conditions are met: (1) their symptomatology fulfills the
diagnostic criteria for panic disorder according to DSM-
IV-TR (APA, 2000); (2) their age is within the range of
18–65 years; (3) they have access to a computer with
internet connection; (4) they are native Romanian
speakers; (5) they provide a written informed consent.
Participants are excluded if any of the following cri-
teria is met: (1) they are currently enrolled in a different
psychotherapeutic program or have received psychother-
apy in the previous 3 months; (2) they present severe
comorbidities, other than a different anxiety disorder or
mild depression (e.g. bipolar disorders, psychotic disor-
ders, substance abuse); (3) they suffer from mental
retardation; (4) their symptoms are aggravated by a
severe medical problem (e.g. ventricular tachycardia,
heart attack, stroke, pulmonary fibrosis, hyperthyroid-
ism, epilepsy); (5) they present suicidal ideation or
behaviors.
Medication use is permitted, but only if the dosage
was constant in the previous month and the same
dosage must remain constant during the trial. Benzodi-
azepines are not allowed, according to existing recom-
mendations [79–81]. All eligible participants must fill
out and return a detailed informed consent form before
starting the trial.
Procedure
Individuals who struggle with panic attacks can freely
access the study website which is publicly available at:
http://studiu.paxonline.ro. The website provides infor-
mation about panic disorder and treatment options, a
description of the present clinical trial, and information
about enrollment. The screening process for eligible par-
ticipants is described below.
The participants start the screening process on the
study website by filling out several online forms, an-
onymously. Firstly, participants must provide an online
informed consent, then provide age and gender informa-
tion. Next, they fill out three key questionnaires: (1) a
screening for the exclusion criteria; (2) a scale for panic
disorder diagnosis and severity (PDSS-SR); and (3) a
screening for psychiatric comorbidities (PDSQ). Only
participants who do not meet any exclusion criteria,
who have a PDSS-SR score of at least 6 (see [82] for
PDSS-SR cutoffs), and have completed the entire PDSQ
screening are invited to provide an email address for fur-
ther contact. Eligible participants are contacted by email
to schedule a semi-structured clinical interview via se-
cured Skype or telephone. The interviews are conducted
by a trained clinical psychologist, who seeks to verify
and confirm the diagnosis of a panic disorder and the
compliance with all the inclusion/ exclusion criteria. At
this point, participants who remain eligible after the
interview receive an email from the principal investiga-
tor with a detailed informed consent and a link to fill
out the online pre-treatment questionnaires. Participants
are required to give their express consent to be included
in the study. Specifically, they reply to the contact email
confirming that they have read the informed consent
and they accept to voluntarily participate in the study.
They must also fill out their name and contact details at
the end of the document. Participants who consent to
this procedure are then randomly allocated to one of the
three study groups.
After randomization, each participant receives an email
containing instructions for the next phase. The guided
participants receive a document with the recommended
pathway for the entire course of treatment, along with in-
structions on how to communicate with their psychother-
apist in the platform. They have a few days to explore the
platform and read the first recommended module before
scheduling their first Skype session with their psychother-
apist. The first session is an introductory session in which
the therapist explains the platform’s architecture and fur-
ther collaboration between therapist and participant. All
the Skype sessions will be audio recorded by the psycho-
therapists. To ensure treatment integrity and adherence to
protocol, an impartial licensed clinical psychologist will
randomly check 3 sessions from the work done with each
patient.
We are using a secured Skype application for the guid-
ance sessions. Skype is using a Peer-to-peer (“P2P”)
technology, meaning that individuals communicate dir-
ectly through their computers rather than through a
third party host. All Skype-to-Skype voice, video, file
transfers and instant messages are encrypted. Skype uses
the AES (Advanced Encryption Standard), which is used
by the US Government to protect sensitive information,
and Skype also uses the strong 256-bit encryption. User
public keys are certified by the Skype server at login
using 1536 or 2048-bit RSA certificates [83].
The unguided participants receive a document with
the recommended pathway for the entire course of treat-
ment and are informed that they may ask for help with
technical problems. This means they may ask for help if
they are unable to access the platform, have problems
with seeing movies, fill in documents or download re-
sources. Although they receive strong recommendations
to work through the modules in a certain order, there
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are no restrictions imposed and patients have access to
all modules and resources, from the very beginning.
Both groups are asked to complete the recommended
modules according to the instructions, and to fill out the
PDSS-SR every two weeks. A pop-up reminder appears
every time the participants access the platform if more
than two weeks have passed since they last completed
the questionnaire. During the treatment period, the par-
ticipants receive a secured link by email, asking them to
fill out the other self-report measurements at the estab-
lished time points according to Table 2.
The waiting list control group does not receive treat-
ment for 12 weeks. Throughout this waiting period, the
participants in this group are required to fill out all the
scheduled questionnaires - at pre-randomization, after
6 weeks, and at the end of the 12 weeks period. After-
wards, they can choose to follow the PAXonline treatment
for panic disorder either independently or with guidance
Table 2 Measurements and time of assessment
Instruments Abbreviation Aim Time of assessment
Clinician administered
Semi-structured clinical interview for DSM-
IV axis I disorders
PDSQ DSM-IV Axis I
disorders
Pre and post intervention (12 weeks)
Self-report ratings
Primary outcome measure
Panic disorder severity scale - self report PDSS-SR Severity of panic
symptoms
Pre-treatment, every two weeks after intervention
commencement, mid-treatment, post-treatment, and at follow-
up: months 1, 3, 6 and 12
Secondary outcome measures
The agoraphobic cognitions questionnaire ACQ Maladaptive
cognitions
Pre-treatment, mid-treatment, post-treatment, and at follow-up:
months 1, 3, 6 and 12
The body sensations questionnaire BSQ Fear of body
sensations
Pre-treatment, mid-treatment, post-treatment, and at follow-up:
months 1, 3, 6 and 12
Patient health questionnaire-9 PHQ-9 Symptoms and
severity of depression
Pre-treatment, mid-treatment, post-treatment, and at follow-up:
months 1, 3, 6 and 12
The work and social adjustment scale WSAS Functional impairment Pre-treatment, mid-treatment, post-treatment, and at follow-up:
months 1, 3, 6 and 12
Psychiatric diagnostic and screening
questionnaire
PDSQ Axis 1 disorders Pre-treatment, post-treatment, and at follow-up: months 6 and 12
Panic attack cognition questionnaire PACQ Catastrophic
cognitions
Pre-treatment, mid-treatment, post-treatment, and at follow-ups
Body vigilance scale BVS Attentional focus on
body sensations
Pre-treatment, mid-treatment, post-treatment, and at follow-ups
Perceived stress scale – 10 PSS-10 Perceived stress levels Pre-treatment, mid-treatment, post-treatment, and at follow-ups
Additional measures
Working alliance inventory short form WAI-S Therapeutic alliance Administered after first and fourth session
Credibility/ expectancy questionnaire CEQ Expectancy for change
and treatment
credibility
Administered at 2 and 6 weeks during intervention
System usability scale SUS Usability and
learnability
Administered at 2 and 6 weeks during intervention
a 5-item shortened version of the Medical
Outcomes Study Social Support Scale
(MOS-SSS)
SS-5 Social support Pre-treatment, mid-treatment, post-treatment, and at follow-ups
OMNI-IV personality disorder inventory OMNI-IV Dependent
personality
Pre-treatment
Personal autonomy questionnaire PAQ Autonomy Pre-treatment
Psycho-education questionnaire PEQ-8 Panic disorder
knowledge
Pre and post-treatment
Drop-out reasons questionnaire DRQ-18 Drop-out reasons After dropping out
Patient feedback questionnaire PFQ Patient satisfaction Post-treatment
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from a therapist. For an overview of measurements and
time of assessment please see Table 2. After the last
follow-up evaluation, additional treatment (4 weeks using
the intervention program and one Skype-session) is avail-
able upon request for all participants in the study.
Interventions
The PAXonline Program for Panic Disorder is a 12-week
internet-based treatment, which consists of cognitive-
behavioral therapy modules, delivered with or without
assistance from a therapist. The Panic Disorder Program
contains 16 modules which address important cognitive
behavioral psychotherapy elements such as: psychoedu-
cation on the disorder and means of intervention; tech-
niques for decreasing neurophysiological hyperarousal;
cognitive restructuring; exposure to feared somatic sen-
sations, alongside with situational (in vivo) exposures
to reduce agoraphobic avoidance; positive emotions
training; problem-solving training; behavioral activation
and cognitive restructuring exercises to reduce symp-
toms of depression; relapse prevention. The treatment
modules and the manual used to guide the intervention in
our RCT were written based on empirically validated
cognitive-behavioral models of anxiety disorders [74–76].
Each module can be completed in 15–40 min and the par-
ticipants are provided with a recommended timetable
(one or two modules per week, depending on the com-
plexity of the content and the homework assignments).
For a more detailed description of the intervention mod-
ules please refer to Table 3.
Guidance
Both treatment groups use the same intervention, but
the first group also receives guidance from a licensed
psychotherapist. The participants in this group have
regular 15–30 min Skype sessions (the length depends
on the complexity of the modules and the needs of each
patient) with their psychotherapist. The first Skype
session is introductory and takes place in the first week
of the treatment, after the participant completed the
module “Anxiety, from normality to pathology”. From
then on, a new session is scheduled almost every week,
but only after the participant has completed the corre-
sponding modules from the recommended timetable.
The sessions are scheduled via an encrypted asynchron-
ous communication system available on the treatment
platform. The participants can also use this system
between two Skype sessions if they need further clarifi-
cations from their therapist.
In total, there are 10 Skype sessions programmed. During
these sessions, held over secured Skype, the psychotherapist
checks if the participant has completed and understood
each module, answers questions, and helps the participant
carry out the recommended exercises. The main purpose of
each online session is to make sure that the patient has
everything he needs in order to put the recommended exer-
cises into practice regularly. That means, according to a be-
havioral model of change [84], the psychotherapist try to
set the necessary antecedents by providing procedural
knowledge (‘I know what I have to do and how to do it”),
self-efficacy (“I believe I can do it”) and motivation (“I’m
convinced that it is worth doing it”). The agenda for Skype
sessions usually involves: review of the week and how the
participant feels, checking the homework assigned in previ-
ous sessions, discussing the last module, demonstrating a
certain exercise or practicing together with the participant
and, at the end, planning homework that should be carried
out until the next session.
For example, in the first and the second session the
psychotherapist works with the patient to develop a case
conceptualization in order to understand the origin of
the problem and the mechanisms by which it is main-
tained. They then discuss the treatment plan so that the
patient understands how the intervention will answer
his/her needs. In the session following the third module,
the psychotherapist briefly explains the hyperventilation
process, describes and demonstrates the breathing con-
trol technique to the patient and then they practice it
once together. In the end, the psychotherapist helps the
patient find a time and place to practice the technique
twice a day. After the interoceptive exposure module,
the psychotherapist explains the rationale of the tech-
nique once more, encourages the patient and does a
few exercises from the list together with the patient
(e.g. breathing for 2 min through a straw, spin in a
chair for 20–30 s, cover the head with a scarf or a
jacket etc.).
The modules and the entire therapeutic environment
of PAXonline are carefully designed in order to facilitate
the psychotherapeutic process (e.g. personalization of
intervention, organizing information and knowledge in
learning objects and use of other effective chunking
strategies, enhancing learnability by using multimedia
content, use of three layers of information, providing im-
mediate feedback to queries, teach-back exercises, pro-
viding a reward after each module completion, offering
access to a personal portfolio and a virtual library etc.)
[10, 85, 86]. The program also contains certain tech-
niques aimed at improving adherence and compliance
with the treatment, e.g. rewards after module completion
(short movies that induce positive emotions), the “medi-
tation of the day”, which is sent via e-mail every 5 days
and contains a link to a short movie or animation that is
meant to be inspirational and/ or motivational. The
participants’ adherence is carefully monitored by meas-
uring overall usage time, the modules and homework as-
signments completed, the time spent on each module
and each module component.
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Therapists
Three licensed psychotherapists with formal training in
cognitive-behavioral therapy and a minimum of 3 years
of clinical experience work with the participants allo-
cated in the first treatment group. They have also par-
ticipated in a 3 months blended course (3 face to face
meetings plus online learning) prior to this study and
were instructed in using the PAXonline platform and
delivering CBT interventions online. The guidance will
be delivered according to a standard treatment proto-
col, but it will also be personalized according to each
participant’s need. During the study, the team meets
once a month for discussions and the main researcher
is available for contact at any time.
Instruments
The selected instruments have already been well vali-
dated and are frequently used in CBT clinical trials for
panic disorder in particular, as well as for other anxiety
and mood disorders. Measures are taken at baseline
(pre-treatment), 6 weeks after the intervention started
(mid-treatment), directly after the intervention (post-
treatment, 12 weeks after baseline), 1, 3, 6 and 12 months
after the intervention ends. All self report measures are
administered through the internet (secured links are
used and all the data are encrypted) and the diagnostic
interviews are conducted through secured Skype or by
phone. The questionnaires, which were not yet validated
for Romanian population, were previously translated in
Table 3 Paxonline panic disorder treatment
Modules Short description
Introductory module. Anxiety, from normality to pathology Psychoeducation concerning fear, anxiety, fight or flight response, the brain circuits
involved in the fear response, etiology of anxiety and treatment directions. Normalizes
patients’ reactions and sets correct expectancies.
Module 1. Understand what’s happening with you Introductory information on panic attacks, panic symptoms and how panic disorder
develops. Study cases and video illustrations. Patients begin to register PD related
behaviors and thoughts using online worksheets.
Module 2. Understand what you have to do Introducing treatment strategies, the treatment plan and boosting confidence and
motivation for change.
Module 3. Reduce hyperactivation through breathing
retraining
Information on the effects of hyperventilation, breathing regulation and abdominal
breathing exercises.
Modules 4 and 5. Reduce hyperactivation through
autogenic training
Inducing relaxation by using autogenic training exercises. Videos and audio files are
provided for practice.
Module 6. Reduce hyperactivation through physical exercises Psychological and biological benefits of physical exercises are presented; how to use
them regularly.
Module 7. Optimizing attentional functioning Attention biases in anxiety and panic disorder. Retraining attention away from the body
and panic-like thoughts.
Module 8. Changing maladaptive conscious cognitions The importance of catastrophic thoughts and attitudes. ICAR technique for cognitive
restructuring:
Identify catastrophic cognitions
Challenge each dysfunctional cognition
Find the Alternative cognition
Repeat the procedure
Module 9. Changing maladaptive unconscious cognitions Cognitive restructuring techniques for unconscious beliefs. Identify personal values and
live by them.
Module 10. Avoidance reduction through interoceptive
exposure
Explain the mechanism of avoidance and prepare for exposure exercises. Reduce fear of
bodily sensations through interoceptive exposure.
Module 11. Avoidance reduction through exteroceptive
exposure
Reduce avoidance behaviors through gradual exposure to feared situations.
Module 13. Positive emotions development Increase positive emotions in daily life through cognitive and behavioral exercises drawn
from positive psychology practices.
Module 14. Relapse prevention Resume the intervention strategies, set the correct expectancies and make a plan to
continue improvement and deal with relapse situations.
Module 12. You learn how to solve problems (optional) Learn to organize problems according to importance and urgency. Implement problem-
solving technique.
Module 15. Reducing depressive symptoms associated with
panic – behavioral activation (optional)
Depression symptoms co-morbid to panic disorder. Behavioral activation techniques.
Module 16. Reducing depressive symptoms associated with
panic – cognitive restructuring (optional)
ICAR technique for cognitive restructuring of dysfunctional cognitions that induce and
maintain depression.
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Romanian and underwent a rigorous back-translation
process to ensure a good adaptation.
Primary outcomes
The primary outcomes are the diagnostic status of the
participants at post-assessment and symptoms of panic
disorder as assessed with the PDSS-SR.
Panic Disorder Severity Scale – Self Report (PDSS-SR).
PDSS is originally a face-to-face interview and was
adapted to a self-report questionnaire by Houck et al.
[87]. The scale contains seven items that measure the
severity of seven dimensions of panic disorder and associ-
ated symptoms: 1) frequency of panic attacks; 2) distress
during panic attacks; 3) anticipatory anxiety (worry about
future panic attacks); 4) agoraphobic fear and avoidance;
5) interoceptive fear and avoidance (i.e., apprehension and
avoidance of bodily sensations); 6) impairment of or inter-
ference with work functioning; and 7) impairment of or
interference with social functioning. The PDSS-SR gener-
ates a total score ranging from 0 to 28, with a higher score
indicating more severe panic symptoms. The question-
naire has good psychometric properties (Cronbach’s alpha
= 0.92, test-retest reliability is 0.83) and is sensitive to
changes following treatment [87]. A cut-off score of six
may discriminate between the presence and absence of
current DSM-IV panic disorder and a cut-off score of
fourteen may discriminate between mild and severe panic
disorder [82].
Diagnostic interview
Panic Disorder is assessed using the Romanian adapted
version of Psychiatric Diagnostic Screening Questionnaire
(PDSQ) [88, 89], which comprises a self-report screening
scale, followed by a semi-structured interview delivered by
a clinician. The PDSQ scale has good psychometric prop-
erties. In the Romanian validation study the mean of the
alpha coefficients was .85 and test–retest reliability was
above .80 for nine subscales, with a mean test–retest of
.85 [89]. A diagnosis of Panic Disorder is considered if
the participant’s score reaches a value of at least 4 on
the Panic scale. The same cutoff is applied for agora-
phobia. Among Romanian psychiatric patients, these
values offered the best balance between sensitivity and
specificity: .90/.72 for panic disorder, and .95/.85 for
agoraphobia [89].
Following the screening procedures, all eligible partici-
pants are interviewed by one of three experienced licensed
clinical psychologists, based on the semi-structured inter-
views included in the PDSQ. This interview has been
developed based on DSM-IV diagnosis criteria. In addition
to Panic and Agoraphobia diagnoses, any other mental
disorder that reached PDSQ screening cutoff point is
assessed during the interview. In order to increase inter-
raters agreement on assessment protocol, the assessors
also participated in a two days training before study com-
mencement. The diagnostic interviews are conducted be-
fore and after treatment by clinicians blind to the
treatment group. At post-treatment diagnostic interview
we are going to count missing data as equivalent to still
meeting diagnostic criteria for panic disorder. This is the
procedure that is recommended according to the
intention-to-treat paradigm and was used in several other
studies (e.g. Hedman et al. [42]).
Secondary outcomes
Secondary outcome measures include quality of life,
stress levels, depressive symptoms, catastrophic cogni-
tions, body vigilance, and fear of bodily sensations.
Depression
The Patient Health Questionnaire (PHQ-9) is a widely
used measure for depression. PHQ-9 contains nine items
and covers nine criteria listed in the Diagnostic and
Statistical Manual of Mental Disorders, 4th Edition
(DSM-IV), in regard to depression [90], requiring re-
spondents to rate the frequency of present difficulties
during the past 2 weeks. Scores indicate presence and
severity of depression, with a maximum score of 27 and
a minimum score of 0. Scores of 5, 10, 15, and 20 indi-
cate mild, moderate, moderately severe, and severe de-
pression, respectively. The internal reliability of the
English version of the PHQ-9 in a clinical population
was in the range of 0.86–0.89 [90], which indicates good
reliability. The test-retest reliability was also good, 0.84,
and the correlation with interview results is very high,
0.84. Furthermore, sensitivity to change — an essential
characteristic of measures used to monitor response to
treatment — has been repeatedly established [90].
Functional impairment
Mundt, Marks, Shear, and Greist [91] developed the
Work and Social Adjustment Scale (WSAS). The WSAS
is a 5-item simple, reliable and valid measure and we
chose it in order to evaluate the self-reported functional
impairment produced by anxiety problems. The scale
items encompass different domains of functioning and
include the following: ability to work, home manage-
ment, social leisure, private leisure, and ability to form
and maintain close relationships. Each item is rated on a
9-point Likert-type scale, ranging from 0 (no impair-
ment) to 8 (very severe impairment). The maximum
total score is 40, with higher scores representing greater
impairment. The WSAS has demonstrated good internal
consistency (range between 0.70 and 0.94) and test-
retest reliability (0.73) and is sensitive to patients’ per-
ceptions of disorder severity [91].
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Attention biases
Body Vigilance Scale (BVS) [92] . We chose this scale in
order to detect any changes in attention vigilance toward
body sensations, a problem targeted in our treatment
program. The 4 items of BVS measure the degree of atten-
tional focus on, and perceived sensitivity towards changes
in bodily sensations, and the amount of time spent scan-
ning for bodily sensations. Research suggests that the BVS
has adequate internal consistency in clinical and nonclini-
cal populations and can be used to assess changes in
bodily attention during cognitive–behavioral treatment for
panic disorder [92–94].
Fear of body sensations
Body Sensations Questionnaire (BSQ) [95]. BSQ was
chosen in order to measure the “fear of anxiety” concept,
an aspect that it is targeted in our intervention program.
This is a 17 item self-report questionnaire and is used to
assess the degree to which sensations associated with
autonomic arousal (e.g., “feeling short of breath,” “heart
palpitations”) are experienced as frightening. Each item
is rated on a five-point scale ranging from 1 (not at all)
to 5 (extremely). The BSQ has good internal consistency
(α = 0.89) and high test–retest reliability (r = 0.79) [96].
BSQ is also sensitive to changes following treatment, so
it is considered to be a good choice for measuring treat-
ment outcomes [95].
Catastrophic cognitions relevant to panic attacks and
agoraphobia
Panic Attack Cognition Questionnaire (PACQ). The
PACQ [97] is a 25-item scale assessing the extent to
which catastrophic cognitions dominated subject’s
thoughts before, during, or after panic attacks. Partici-
pants are asked to rate each thought on a 4-point scale
indicating their level of preoccupation with that thought
from 0 = not at all to 3 = totally dominates my thoughts.
The total PACQ score is the sum of the 25 item scores.
This scale was composed from items generated from the
DSM-III-R description of panic attacks, from ideation
reported in the anxiety literature, and from interviews
with patients. The fifth edition of DSM is currently in
use, but analyzing the DSM versions, we could conclude
that the panic disorder diagnostic criteria have not chan-
ged much from DSM-III-R to DSM-5 (APA, 2013).
There is still the distinction between autonomic nervous
system symptoms (11 symptoms) and catastrophic
cognitions (fear of dying, fear of losing control or going
crazy). In the DSM-5 panic disorder and agoraphobia
are two separated diagnoses, but other than that there
are no major changes, at least not concerning the cata-
strophic cognitions, which are assessed through PACQ.
The PACQ has good internal consistency as calculated
by Cronbach alpha (.88). It has also been shown to
successfully differentiate between individuals with and
without panic attacks [97].
Agoraphobic Cognitions Questionnaire (ACQ) [95].
The ACQ is a 14 item self-report questionnaire, which
assesses the frequency of frightening or maladaptive
thoughts about the consequences of panic and anxiety.
Each item is rated on a five-point scale ranging from 1
(thought never occurs) to 5 (thought always occurs when
I am nervous). The ACQ has shown good internal
consistency (α = 0.82) and test–retest reliability (r = 0.79)
[96]. ACQ was also proven to be sensitive to changes fol-
lowing treatment [95]. Both measures, PACQ and ACQ,
were chosen because they measure catastrophic cogni-
tions relevant to panic disorder and agoraphobia, a very
important aspect that is directly targeted in our treatment.
Perceived stress
Perceived Stress Scale – 10 (PSS-10) is a short and easy
to use questionnaire which proved acceptable psycho-
metric properties and is recommended for the assess-
ment of perceived stress, both in practice and research
[98]. PSS-10 [99] measures the degree to which one per-
ceives aspects of one’s life as uncontrollable, unpredict-
able, and overloading. Participants are asked to respond
to each question on a 5-point Likert scale ranging from
0 (never) to 4 (very often), indicating how often they
have felt or thought a certain way within the past month.
Scores range from 0 to 40, with higher composite scores
indicating greater perceived stress. The PSS-10 has dem-
onstrated good internal consistency (0.89) and also good
divergent and convergent validity [98, 100].
Additional measures
Treatment credibility and patient expectancies
The Credibility/Expectancy Questionnaire (CEQ) of
Devilly and Borkovec is used to measure expectancy for
change and treatment credibility. It comprises six ques-
tions, four on “thinking” and two on “feeling” and they are
rated on a Likert-type scale from 1 to 9. The scale has
shown good internal consistency (expectancy, α = .79–.90;
credibility, α = .81–.86) and test–retest reliability (expect-
ancy, 0.82; credibility, 0 .75) [101]. CEQ is administered
twice; after the first and the fourth Skype session for the
guided participants, and at 2 and 6 weeks during interven-
tion for the unguided participants.
Working alliance
Working Alliance Inventory-Short Form (WAI-S)
[102, 103]. The WAI-S is a 12-item client self-report
measure to assess the working relationship and thera-
peutic bond between client and therapist. This measure is
commonly used in CBT treatment outcome studies’,
including those in which treatment is delivered remotely.
The 3 subscales are: agreement on goals for treatment,
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agreement on therapeutic tasks, and perception of thera-
peutic bond. Ratings are given on a 7 - point Likert scale,
with higher scores reflecting a stronger working alliance.
Busseri and Tyler [104] reported that the WAI - S has good
internal reliability for the composite score (alpha = .91) and
the subscales (alpha = .73 to .86). WAI-S is administered
twice, after the first and the fourth Skype session, according
to existing recommendations [105].
Personality traits (dependent personality and personal
autonomy)
OMNI-IV [106]. Derived from the 375-item OMNI
Personality Inventory, the 210-item OMNI-IV measures
abnormal personality traits and assesses personality disor-
ders. It is composed of 10 Personality Disorder scales
based on the DSM-IV Axis II personality disorder criteria.
For our study we use the Dependent Personality Subscale,
which has 15 items. Previous studies showed good internal
consistency, α = .80–.82 and also test-retest reliability,
0.80–0.84 [106]. In the Romanian sample used to validate
the scale internal consistency varied between 0.79 and
0.88 and test-retest reliability was 0.67 [107].
Personal Autonomy Questionnaire (PAQ) [108]. The
PAQ is a 36-item questionnaire designed to measure
four dimensions of personal autonomy: cognitive auton-
omy, behavioral autonomy, emotional autonomy and
value autonomy. Ratings are given on a 5-point Likert
scale, with higher scores reflecting a stronger personal
autonomy (reverse score items: 1, 4, 12, 13, 14, 15, 19,
29, 34, 35 and 36). PAQ has good internal consistency,
α = .80 and also test-retest reliability, 0.86. [108].
Perceived social support
The SS-5 is an abbreviated version of the Medical Out-
comes Study Social Support Scale (MOS-SSS) [109].
This is a 5 item short and reliable measure for assessing
perceived social support, a putative predictor or moder-
ator of treatment outcome. Each item is scored on a 5-
point Likert scale and the items are summed for a total
score ranging from 5–25. The SS-5 proved to have ad-
equate test-retest reliability (0.92) and internal consistency
(α = .88). Equivalence between paper and web-based ad-
ministration has also been demonstrated [110].
Usability
The System Usability Scale (SUS) is one of the oldest
questionnaires used to evaluate usability of a system and
was designed in 1986 by Broke. The SUS consists of 10
items scored on a 5-point Likert scale (1-5), with odd-
numbered items worded positively and even-numbered
items worded negatively. The scale has been used in
hundreds of studies and the psychometric qualities are
adequate (α = .88). For many years the scale was consid-
ered unidimensional, but recent studies have shown that
it measures not just usability, but also learnability of a
new system [111].
Sociodemographic questionnaire
To evaluate the sociodemographic characteristics of the
participants, we used a 7 questions survey referring to:
environment (urban or rural), ethnicity, marital status,
education, occupation, income levels and computer skills
(1 to 10).
Psychoeducation
Psycho-Education Questionnaire (PEQ). In order to
evaluate the information participants have about panic
disorder and its treatment, we used a brief knowledge
test that consisted of an 8-item questionnaire. Seven of
the questions used are multiple choice questions and the
last one is a self-evaluation question concerning the level
of knowledge about PD and its treatment (from 1 – “I
don’t know anything”, to 10,” I know almost everything”).
Adherence to treatment and homework compliance
Adherence to treatment and completion rates will be
assessed. Number of modules completed, time spent in
total, time spent on each module, and usage of the support
will be analyzed to identify potential mediating effects.
Frequency of use of anxiety reduction strategies
In order to assess how frequent the anxiety reduction
techniques were used we have developed a 10 items
questionnaire. Eight of these questions are scored on a
5-point Likert scale (0-never and 4-daily or almost daily)
and the last two are open ended questions: “Which tech-
niques helped you the most?” and “Which are the tech-
niques that you plan on using after the end of the
intervention?”
Patient satisfaction
The Patient Feedback Questionnaire (PFQ). We have
developed a 14-items questionnaire to evaluate the
patients’ satisfaction with the platform and some other
aspects (the quality and utility of different components of
the platform). Other items refer to giving improvement
suggestions, what they like most, if they would use it again
or recommend it to a friend with anxiety problems.
Drop-out reasons
In order to find the reasons or motives participants had
for dropping out of the study, we have developed an 18-
item questionnaire. Each item is considered to be a pos-
sible motive (e.g. lack of motivation, lack of time, different
expectations, exacerbation of symptoms, interface is too
complicated, the treatment pace is too slow or too fast,
finding another treatment, getting better, important life
events etc.).
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Randomization
Participants who return the informed consent and meet all
the required criteria are randomly allocated to one of the
three conditions (1:1:1 allocation ratio). The randomization
process is done by a software that was developed to imple-
ment a minimization algorithm [112], that assures a bal-
anced randomization between groups with respect to
certain predefined prognostic (stratification) factors. In this
study, two stratification factors have been considered: SE-
VERITY (3 levels according to PDSS-SR screening scores;
level 1: 6 to 13 points; level 2: 14 to 20 points; level 3: 21 to
28 point) and CHRONICITY (2 levels; more or less than
6 months since the beginning of PD) of panic disorder. The
minimization method has been shown to outperform
simple randomization in achieving balanced groups
[113] and its use in clinical trials has been previously
recommended as a better option than other
randomization methods (e.g. [113–115]). Before each
allocation, the algorithm computes an imbalance score
for the three available treatments, taking stratification
factors levels into account. The treatment with the low-
est imbalance score is then given preference when assign-
ing treatments, but the allocation probability varies for
each patient, depending on the actual level of imbalance
[116]. This method is preferred because it avoids the
deterministic allocation of pure minimization [117]. The
allocation is done by an independent researcher and is
concealed, i.e. patients and researchers have no knowledge
and no control over the allocation of participants when
they randomize a participant with the computer program.
Blinding
Taking the characteristics of our research into consider-
ation, it is impossible to keep patients or psychothera-
pists blind to the study procedures and intervention. All
participants are provided with detailed information
about the aims and the methodology of the study. They
can request more information about the study and they
have the right to terminate participation at any time.
The personnel in charge with the clinical interviews, on
the other hand, will be blind to the treatment group allo-
cation. We specifically instruct the participants not to
mention group allocation at the post-treatment inter-
view, but also test whether blinding was successful. The
clinicians who conduct the diagnostic interviews are re-
quired to describe in their report if the participants dis-
closed their study group, directly or indirectly.
Sample size
The effect sizes reported between guided and unguided
interventions are quite heterogeneous with small to
medium Cohen’s d size effects between 0.27 [64] and .42
[14]. Taking into consideration that, in most part, the
guidance in previous studies was in fact low-intensity
guidance, and that more support from a therapist yields
larger effects [21, 62, 63], we expect an effect size of 0.5
(Cohen’s d) between guided and unguided treatment for
PD. Based on this effect size, a power of 0.80, and an
alpha level of 0.05, we would need 51 subjects in each
condition. This recommended sample size has been in-
creased to accommodate an attrition rate of 20 %. Thus,
the study aims to achieve a sample of 192 participants.
Statistical analysis
All statistical analyses will be performed using the IBM
SPSS Statistics version 20. The main analyses will be con-
ducted on the intention-to-treat samples (all randomised
participants, regardless of protocol adherence). Following
current standards [27, 28], a linear mixed effects models
approach with full information maximum likelihood esti-
mation will be used. This approach has been recom-
mended since it uses all available data and can handle
missing data appropriately [118, 119]. The approach is
based on the assumption that data are missing at random,
and does not assume that missing data remain stable, as
in the last-observation-carried-forward (LOCF) approach
[119, 120]. Significance testing of dichotomous data such
as diagnostic status will be conducted with chi-square
tests. Calculations of within- and between-groups effect
sizes (Cohen’s d) will be based on the pooled standard
deviations. Regression analyses will be used to identify
predictors of treatment outcome. Moderation and medi-
ation analyses will be conducted with multiple regression
models, using the PROCESS macro for SPSS [121], a com-
putational technique that can compute both simple and
complex moderation and mediation models. Effect sizes
for significant effects will be indicated by Cohen’s f.
Consistent with CONSORT [77] and SPIRIT [78]
recommendations we mention our intention to perform
secondary analyses for minimal treatment users, defined
as participants that complete at least 5 of the recom-
mended modules, have at least 3 of the available guid-
ance sessions (this is available only for the Skype-guided
group) and use the intervention program for at least
80 min. This definition is based on the specific of our
intervention program and the criteria used in other
studies [27, 119].
Discussion
The prevalence of mental health problems is very high
and bears considerable suffering and burden worldwide.
However, only a small percentage of the affected individ-
uals reach out and receive treatment for their problems.
There are many barriers at different levels, yet a viable
solution to increase access to quality treatment resides
in the possibilities provided by internet-based cognitive
behavioral treatments. Although several ICBT programs
have been tested with strong positive results and even
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integrated into regular health care, there are countries
where validated internet-based interventions are yet to
be developed. The present trial aims both to validate the
overall efficacy of the first Romanian ICBT program for
panic disorder, and to investigate aspects that are novel
to ICBT, such as brief therapist guidance sessions via
secured Skype.
There are still divergent results regarding the effect of
therapist guidance in ICBT [18, 31, 56–58], and the effi-
cacy of Skype-based (or equivalent) therapy sessions in
ICBT have not been previously investigated. Thus, a
central focus of our trial is to test the additive effect of
therapeutic guidance via secured Skype in self-help
ICBT programs. Specifically, the current study design al-
lows us to assess the effect of the same self-help inter-
vention modules in two treatment conditions: therapist
guided via Skype vs. unguided self-directed intervention.
There is a general consensus that internet-based therapy
can be efficient for many psychiatric conditions, but not
all the patients benefit from it [44]. Thus, there is an
increasing interest to describe the characteristics of the
patients who would benefit the most from this type of
interventions. Taking into consideration this issue, add-
itional exploratory analyses of potential predictors, moder-
ators or mediators will be made. Patients’ treatment
expectations, personality traits (e.g. personal autonomy),
and usability of the online treatment program could prove
to be key factors of treatment adherence and outcome, es-
pecially in the unguided self-help treatment group.
Several possible limitations should be noted. Firstly,
the study sample size is large enough to reach our main
research objectives, but will not permit us to perform
detailed subgroup analyses. However, we expect to
identify candidate predictors of treatment outcome that
could be tested directly in future studies with larger
samples. Secondly, the control group, for ethical reasons,
will receive treatment in the second stage of the trial,
thus the control group will not be available at follow-up.
Furthermore, most of the recruitment will be made from
the community, through advertisements in the media
and on the study website, which could lead to a self-
selected sample. Regarding the latter limitation, several
findings from recent studies suggest that sampling bias
may not affect the generalizability of internet-based tri-
als. For example, Titov et al. [122] revealed that patients
undergoing web-based treatments resemble national
samples and present disorders as severe as those under-
going traditional psychotherapy. Another example is a
recent study by Donkin et al. [123] on sampling bias in
an internet-based clinical trial for depression. The
authors revealed that out of 35 potentially biasing fac-
tors, only 4 were associated with consenting likelihood,
accounting for limited variance in explaining participation,
and none were associated with the primary outcomes.
Future research will be required, nonetheless, to investi-
gate whether the results from the PAXonline trial can be
generalized to samples in regular mental health care
settings.
In Romania, the need for easily accessible treatment
programs for mental disorders is very high. 76.4 % of the
individuals with mental health problems do not have
access to any form of treatment, and only approximately
11.5 % receive psychological or psychiatric treatment
[12]. Internet-based treatments can offer a viable alter-
native solution to the current situation, considering that
internet access has increased rapidly over the past years
in Romania (in 2004 only 6 % households had access to
the internet, and presently the number has increased to
61 % [124]). However, although ICBT advantages are eas-
ily recognized, both patients and psychologists in Romania
have a reserved attitude towards using internet-based psy-
chological intervention [125]. By developing rigorous clin-
ical trials on the efficiency of Romanian ICBT programs,
we can increase the uptake of these solutions, and thus
have a significant positive impact on the quality of life,
both at an individual and national level.
Trial status
Trial start date: May 22, 2014.
Currently recruiting (Ncurrent = 99 as of December
15, 2015).
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